In today’s briefing:
- Mar24 Nikkei 225 Rebal: Zozo (3092) And Other ADDs Update
- Hogy Medical (3593): A Prescription for Renewed Growth
Mar24 Nikkei 225 Rebal: Zozo (3092) And Other ADDs Update
- ZOZO Inc (3092 JP) is +10% since the close after the Nikkei 225 inclusion announcement vs Nikkei225 +2%. Fellow upweight Nitori is up too. Disco and Socionext are up less.
- All three inclusions and one upweight see considerable inclusion demand when compared to active holdings. Some more than others.
- Some trades here are more interesting than others, still. Cumulative excess volumes are one guide. Fundamentals, and flow dynamics are another.
Hogy Medical (3593): A Prescription for Renewed Growth
- NAVF and Dalton invest heavily in Hogy Medical, eyeing its market dominance and growth potential in disposable surgical equipment
- Despite past underperformance, NAVF’s proactive engagement signals a push for a more aggressive overseas expansion
- We see a number of continued catalysts for future shareholder value enhancement and improved corporate governance position